1-nitroso-2-(3-pyridyl)piperidine
| Title | Journal |
|---|---|
| In vitro metabolism of N'-Nitrosonornicotine catalyzed by cytochrome P450 2A13 and its inhibition by nicotine, N'-Nitrosoanatabine and N'-Nitrosoanabasine. | Chemico-biological interactions 20161225 |
| Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers. | Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 20091201 |
| Glucuronidation of tobacco-specific nitrosamines by UGT2B10. | Drug metabolism and disposition: the biological fate of chemicals 20080501 |
| Role of human cytochrome P450 (CYP) in the metabolic activation of nitrosamine derivatives: application of genetically engineered Salmonella expressing human CYP. | Drug metabolism reviews 20020801 |
| Analysis of tobacco-specific nitrosamines in Moldovan cigarette tobacco. | Journal of agricultural and food chemistry 20020508 |
| Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase. | Environmental and molecular mutagenesis 20010101 |
| Smoke yields of tobacco-specific nitrosamines in relation to FTC tar level and cigarette manufacturer: analysis of the Massachusetts Benchmark Study. | Public health reports (Washington, D.C. : 1974) 20010101 |